Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The needs for new antibiotics continue to grow due to the widespread of antibiotic-resistant pathogens causing lifethreatening
infections. The bacterium methicillin resistant Staphylococcus aureus expresses a widespread virulence factors and
antimicrobial resistance determinants that lead to increasing mortality, morbidity, and health care costs. The endophytic
Streptomyces species that resides in the living tissues of plants are generally considered a source that has huge potential
for the novel bioactive molecules, with medicinal and pharmaceutical properties. This study is aimed to determine the anti-
MRSA activity of the bioactive compounds derived from endophytic Streptomyces sp., SUK 25 which was isolated from the
root tissues of Zingiber spectabile. The production of secondary metabolites by this strain was optimized through Thornton�s
broth media. Isolation, purification, and identification of the bioactive compounds were carried out using TLC, column
chromatography, HPLC, and FT-IR, HR-LCESIMS and NMR. During primary and secondary screening, SUK 25 showed potential
activity against several strains of MRSA ATCC. Bioactivity test was carried out using disk diffusion method for thirteen
fractions isolated using column chromatography methods to determine the bioactivity of each fraction against MRSA ATCC
43300. Seven bioactive compounds were isolated and identify. Determination of the gene transcriptional profile of MRSA
ATCC 43300 treated with subinbibitory concentration of CAP and cyclo (L-prolyl-L-valine) revealed significant modulation of
gene expression with up regulation of 90 genes and down regulation of 131 genes. In conclusion, this study demonstrates that
endophytic Streptomyces SUK 25 has the ability to produce several natural compound derivatives with potential bioactivity
against MRSA with low cytotoxicity against HepaRG cells.
Biography
Dr. Muhanna is a postdoctoral fellowship at Faculty of Civil Engineering and Built Environment (FKAAB). Universiti Tun Hussein Onn Malaysia. BSc. Medical Microbiology, diploma in Medical Microbiology. MSc. Medical Research at Universiti Sains Malaysia (USM), Penang, Malaysia. PhD in Biomedical science from Faculty of Health Sciences, Universiti Kebangsaan Malaysia (UKM).
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals